Delivery Order SPE2DB20D1109-SPE2DB23FP91J
Award Date
9/12/23
Potential Completion Date
9/13/23
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,239.50, is for the supply of HEMABATE 250 MCG/ML AMPULML, a pharmaceutical product. The contract has an ultimate completion date of January 22, 2025 and is a firm fixed-price contract. This contract does not have a set-aside designation, indicating it was competitively awarded....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $4,862.12, is for the delivery of HEMABATE 250 MCG/ML AMPULML, a pharmaceutical product. This is a Firm Fixed Price delivery order contract with an ultimate completion date of October 8, 2024. The contract was awarded on October 7, 2024 and does not have a set-aside designation. AmerisourceBergen, a major...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,586.36 firm fixed-price delivery order is for the supply of HEMABATE 250 MCG/ML AMPUL/ML, a pharmaceutical product, with an ultimate completion date of October 23, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,646.59, is for the delivery of HEMABATE 250 MCG/ML AMPULML, a medication used in healthcare settings. The contract has an ultimate completion date of November 19, 2024 and is a Firm Fixed Price Delivery Order. It is not designated as a set-aside contract....
This federal contract award is for the delivery of HEMABATE 250 MCG/ML AMPUL/ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $20,848.30 firm fixed-price delivery order was issued to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on September 24, 2022 with a completion date of September 26, 2022. Amerisourcebergen is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,609.63 firm fixed-price delivery order is for the supply of HEMABATE 250 MCG/ML AMPULML, a pharmaceutical product, with a completion date of December 13, 2024. The award is not designated under any specific set-aside program. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $4,058.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HEMABATE 250 MCG/ML AMPULML, a pharmaceutical product, with a performance period through March 4, 2025. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This is a $3,329.01 firm fixed-price delivery order contract awarded by the Medical Supply Chain division of the U.S. Department of Defense's Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation. The contract is for the supply of HEMABATE 250 MCG/ML AMPULML, a pharmaceutical product, with a period of performance through May 10, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $12,336.54 firm fixed-price delivery order is for the supply of HEMLIBRA 105 MG/0.7 ML VIAL 0.7ML, a specialty medication. The contract has an ultimate completion date of March 28, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $33,409.40 firm fixed-price delivery order is for Hemlibra 150 mg/mL vial, a specialty medication. It has an ultimate completion date of August 2, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...